Clinical Trials
3 trialsNCT06787664 2026-04-13
A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Chordoma
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2 Active not recruiting
NCT04670679 2026-03-25
FLAGSHP-1
Erasca, Inc.
Phase 1 Active not recruiting
NCT02936102 2025-11-14
A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.
Novartis
Phase 1 Terminated